Martin Ferron
Analyst · Canaccord Genuity
Thanks, Jason, and a very good morning to everyone. Before I get into the meat of my prepared remarks, I would like to clear up some possible confusion around a section of my press release quote, which states that, we hope to post a strong outcome for Q4 similar to last year. Before we recently announced two significant acquisitions, the consensus EBITDA estimate to Q4 was $18 million, which is a number we posted last year. If we achieve that again this year, despite additional one-off acquisition related costs, we will have produced $91.5 million of EBITDA for 2018, as Jason just mentioned. This represents a 45% year-over-year growth rate, which is triple our target rate, after we also grew EBITDA by 24% in 2017. I hope that nobody will be disappointed by this pace of growth. And we also stated in the press release that we anticipate both acquisitions to close in Q4. To add further clarity, the first one could close as early as tomorrow and the second one, perhaps by December 1. However, it is difficult to assess incremental EBITDA numbers until we know a date certain. And so my press release quote implies no extra EBITDA. Clearly, when the deals do close, we can better assess the EBITDA impact on Q4, but I contend that we should perhaps fully focus on 2019 and 2020 outcomes. Okay, with that said, I'm now going to cover three topics today. Earnings per share, EPS, senior debt-to-EBITDA ratio and stock-based compensation. On EPS, pretty much exactly 6 months ago on the Q1 earnings call, I forecasted basic earnings could reach $1 a share, possibly as early as 2020. This piqued interest in the investment community, as I believe the statement put us on the map as a profitable company. Well, here we are today with a basic earnings prediction of possibly $1.60 per share for 2019, assuming that both acquisitions close as expected before the end of the year. This impressive pace of growth will lead to returns on equity north of 20%, which is a level well ahead of any other company in the engineering and construction segment. Apart from the significant financial returns expected from the acquisitions, our organic growth steps will continue to contribute nicely to the overall growth picture. In particular, I am pleased to announce that we'll be moving into our new shop and maintenance facility by mid-November, ahead of schedule for a major internal project that we have brought in on budget. Demand momentum for external maintenance services continues to build, and the timing of the shop opening coincides almost perfectly, with the expected influx of major assets from one of the acquisitions. In the meantime, the operating environment in our core oil sands market continues to improve, with customers looking to us to take on much increased volumes of recurring earthworks. This should also be no surprise if we secure additional term contracts before the end of the year, which will underpin our earnings expectations. I would say, the oil sands bidding activity is brisk, and we are hopeful of building on our revenue diversification efforts in the near term. The bidding activity will likely also include packages related to the recently announced major LNG project in British Columbia. Another notable aspect of our growth story, I will mention, is that we are not sacrificing EBITDA margin as revenues climb steeply. In 2016, we printed 23% EBITDA margin on just $213 million of revenue. This year to date, we have recorded 26% margin on $279 million of revenues. The next year, research analysts expect us to have about 23% margin on around $700 million of revenue. Turning out to our senior debt-to-EBITDA issue. I mentioned on the last call that one of my fundamental business principles is to keep this below 2x on a current-year basis. Now as we will be using a much expanded and extended senior debt facility to fund the two acquisitions, the ratio is likely to be around 2x for a period. This is why you may see us layering some junior debt into the capital structure if we can secure it on attractive terms. Also as one of the acquisitions is an asset purchase, our commercial banks indicate, we'll not take into account the associated trailing 12 months of EBITDA. Therefore, on this backwards-looking basis, the ratio will likely just exceed three until we record some EBITDA with the acquired assets. Hence the related debt facility covenant will be set initially at 4x. We will certainly not breach the covenant, as a recent research report perhaps inferred. This situation does though provide added impetus for us to look at securing some junior debt. Also as mentioned in the press release announced in the second acquisition, it is our clear intention to reduce our leverage by around $150 million over the next three years from operating cash flow. We should get off to a good start with this deleveraging, as we do not anticipate paying any taxes, cash taxes that is, until 2020. Additionally, I would like to stress here that importantly, we will not, I repeat, not be issuing equity at anywhere near current stock price levels to raise incremental capital. Interestingly, one of my executive team members commented recently, "Martin, you really hate equity dilution of any kind, don't you?" He was right, I hate it, which brings me onto my final topic of stock-based compensation. The mark-to-market cost of this aspect of our compensation is over $9 million so far this year, resulting in a reduction of $0.26 of basic earnings per share. This is mainly due to the potential extra cost of cash-settled defers stock units held mostly by long-standing members of our board. On the other hand though, I want to draw attention to the fact that in recent years, we appointed a trustee to buyback over 2.7 million shares at an average cost of around $4.78 per share to hedge our equity, settle restricted and performance stock units issued annually to key employees. The value of those shares today is over $20 million, more than we paid for them. And the remaining part held interest will last several more years. The basis for this shareholder friendly hedge was that I learned in previous cyclical downturns that equity grants made at low stock prices can be extremely dilutive. So the main takeaway from these prepared remarks should be that Martin really does hate equity dilution. With that, I would like to turn the call back over to Melissa, the operator, for the Q&A segment.